Gentyx
Antibiotic
About
Gentyx® is a brand of Gentamicin Sulfate Injection. It’s an aminoglycoside based antibiotic agent used in the treatment of several bacterial infections such as bone infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, and sepsis among others. Each 2ml Ampoule of Gentix® contains 80mg Gentamicin Sulfate. Gentix® is a registered trademark of Carpa Healthcare limited.
Administration
Gentyx® is administered intravenously or intramuscularly (IV/IM). The recommended dose and precautions for intramuscular and intravenous administration are identical. Gentamicin when given intravenously should be injected directly into a vein or into the drip set tubing over no less than three minutes. If administered by infusion, this should be over 20 – 30 minutes and in no greater volume of fluid than 100 ml. Longer infusion times of up to 60 minutes may be used, in particular for a once daily dosing regimen. Once daily dosing should only be administered through the intravenous route as recommended by a physician.
Side Effects
Gentyx® may cause side effects. Inform your physician if any of these symptoms persist: If used during pregnancy, it can cause harm to the developing fetus.
Contraindications
Gentyx® may be contracindicated in: • Hypersensitivity to the active substance or to any of the excipients • Myasthenia gravis.
Prescription Information
Gentyx® is an aminoglycoside antibiotic with broad-spectrum bactericidal activity. It is indicated to treat severe infections caused by bacteria susceptible to gentamicin such as, but not limited to: • Urinary tract infections • Respiratory tract infections • Intra-abdominal infections • CNS infections • Severe neonatal infections It is usually active against most strains of the following organisms: Escherichia coli, Klebsiella spp., Proteus spp. (indole positive and indole negative), Pseudomonas aeruginosa, Staphylococci, Enterobacter spp., Citrobacter spp. and Providencia spp. Consideration should be given to official local guidance on the appropriate use of antibacterial agents.
